🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesGLP-1 and peripheral arterial disease — looking for input Page 3

GLP-1 and peripheral arterial disease — looking for input

dan_philly Thu, Mar 21, 2024 at 8:07 PM 44 replies 3,088 viewsPage 3 of 9
emily_PDX
Member
245
1,123
Nov 2024
Portland, OR
Mar 23, 2024 at 9:52 AM#11
ingrid_STO said:
Vitamin deficiency cascade with cardiovascular risk: after 6+ months of reduced food intake, I developed a subtle but important pattern: low B12 →…

Thank you — that is the clearest version of this I have read, and I have read a lot of them.

Last edited: Mar 23, 2024 at 11:52 AM
7 5julia.endo, JessicaM_2024, TomFromTexas and 4 others
Reply Quote Save Share Report
NurseKim_ATL
Senior Member
1,678
7,234
Feb 2024
Atlanta, GA
Mar 23, 2024 at 6:43 PM#12

Clinical perspective, offered as context rather than as advice.

Anti-inflammatory mechanisms of GLP-1 agonists and cardiovascular risk: beyond weight loss, GLP-1R activation directly suppresses NF-κB signaling, reduces NLRP3 inflammasome activation, and decreases monocyte/macrophage adhesion to endothelium[1].

Clinical correlates: hsCRP reduction of 30-60% (consistently seen across trials), reduced carotid intima-media thickness, and decreased coronary plaque inflammation on PET imaging.

These anti-inflammatory effects likely contribute to the cardiovascular benefit seen in SELECT — and may explain benefits beyond what weight loss alone would predict.

References:
[1] Hogan AE, et al. Diabetologia. 2014;57(4):781-784.
8 6raj_cambridge, ingrid_STO, pete_nash and 5 others
Reply Quote Save Share Report
amsterdam_pete
Senior Member
1,567
6,789
Feb 2024
Netherlands
Mar 24, 2024 at 3:34 AM#13
Dr.NateNeph said:
SUSTAIN-6 was the first CVOT to show cardiovascular benefit with semaglutide, relevant to cardiovascular risk.

6 month update on cardiovascular risk: down 64 lbs, off blood pressure meds, A1C normalized. Genuinely life-changing.

9 7CanadaChris, ZaraB_AL, JakeSmashed95 and 6 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
PeptideSynthNJ
Member
234
1,234
Aug 2024
Princeton, NJ
Mar 24, 2024 at 12:25 PM#14
dan_philly said:
SELECT is the trial that changed the framing of this class, because it was an outcome trial rather than a weight trial: about a 20% relative reduction…
dan_philly said:
...we're creating a generation dependent on cardiovascular risk...

I understand the concern, but consider this analogy: are we "creating a generation dependent on" blood pressure medication? Cholesterol medication? Thyroid medication?

Obesity is a chronic disease with biological drivers. Treating it with medication is no different from treating any other chronic condition. The "dependency" framing implies weakness or moral failure — neither of which is accurate.

If ongoing medication is what keeps someone healthy, that's successful treatment, not dependency.

Last edited: Mar 24, 2024 at 4:25 PM
10 8MikeKY_noInsulin, Dr.RaviCardio, jennifer_SEA and 7 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Mar 24, 2024 at 9:16 PM#15

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful.

11 9PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 8 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register